Origin & tradition
Not traditional: marine omega-3s entered medicine through cardiovascular epidemiology and large randomized trials.
Western tradition · Essential fatty acids
Among the most-trialed supplements in medicine, with emerging evidence on biological-age slowing.
Not traditional: marine omega-3s entered medicine through cardiovascular epidemiology and large randomized trials.
Key active: EPA & DHA (marine omega-3 fatty acids).
EPA and DHA modulate inflammation (resolvins), membrane function, and triglycerides; the DO-HEALTH trial reported small reductions in biological-aging markers and infections in older adults.
Evidence summary
Very large human RCT base; aging markers emerging (DO-HEALTH)
EPA and DHA modulate inflammation (resolvins), membrane function, and triglycerides; the DO-HEALTH trial reported small reductions in biological-aging markers and infections in older adults.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-06. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Compare the evidence
Verified suppliers
Tell us what you need and we will source verified suppliers for you.